Dapagliflozin and apparent treatment-resistant hypertension in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial

被引：0

作者：

Ostrominski, John ^{[1
]}

Vaduganathan, M. ^{[1
]}

Selvaraj, S. ^{[2
]}

Claggett, B. ^{[1
]}

Desai, A. ^{[1
]}

Jhund, P. ^{[3
]}

Kosiborod, M. ^{[4
]}

Lam, C. ^{[5
]}

Inzucchi, S. ^{[6
]}

Martinez, F. ^{[7
]}

De Boer, R. ^{[8
]}

Hernandez, A. ^{[9
]}

Shah, S. ^{[10
]}

Mcmurray, J. ^{[3
]}

Solomon, S. ^{[1
]}

机构：

[1] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA

[2] Duke Univ, Med Ctr, Durham, NC 27706 USA

[3] Univ Glasgow, Glasgow, Lanark, Scotland

[4] St Lukes Mid Amer Heart Inst, Kansas City, MO USA

[5] Natl Heart Ctr Singapore, Singapore, Singapore

[6] Yale Sch Med, New Haven, CT USA

[7] Univ Nacl Cordoba, Cordoba, Argentina

[8] Univ Med Ctr Groningen, Groningen, Netherlands

[9] Duke Clin Res Inst, Durham, NC USA

[10] Northwestern Mem Hosp, Chicago, IL 60611 USA

来源：

EUROPEAN JOURNAL OF HEART FAILURE | 2023年 / 25卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：41 / 41

页数：1

共 50 条

[41] Implementation Approaches in Heart Failure With Mildly Reduced and Preserved Ejection Fraction
Bhatt, Ankeet S.
Filippatos, Gerasimos
Vaduganathan, Muthiah
[J]. JACC-HEART FAILURE, 2024, 12 (04) : 628 - 630
[42] Cardio-Renal-Metabolic Overlap, Outcomes, and Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction
Ostrominski, John W.
Thierer, Jorge
Claggett, Brian L.
Miao, Zi Michael
Desai, Akshay S.
Jhund, Pardeep S.
Kosiborod, Mikhail N.
Lam, Carolyn S. P.
Inzucchi, Silvio E.
Martinez, Felipe A.
de Boer, Rudolf A.
Hernandez, Adrian F.
Shah, Sanjiv J.
Petersson, Magnus
Langkilde, Anna Maria
McMurray, John J. V.
Solomon, Scott D.
Vaduganathan, Muthiah
[J]. JACC-HEART FAILURE, 2023, 11 (11) : 1491 - 1503
[43] First and Repeat Episodes of Worsening Heart Failure in Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction: An Analysis of Deliver
Jhund, Pardeep S.
Claggett, Brian
Talebi, Atefeh
Gasparyan, Samvel
Butt, Jawad
Wilderang, Ulrica
Vaduganathan, Muthiah
Desai, Akshay S.
De Boer, Rudolf A.
Hernandez, Adrian F.
Inzucchi, Silvio E.
Kosiborod, Mikhail N.
Lam, Carolyn S.
Martinez, Felipe
Shah, Sanjiv J.
Lindholm, Daniel
Petersson, Magnus
Langkilde, Anna Maria
Solomon, Scott D.
McMurray, John J.
[J]. CIRCULATION, 2022, 146 (25) : E586 - E586
[44] Cost-utility analysis of add-on dapagliflozin in heart failure with preserved or mildly reduced ejection fraction
Tang, Yi
Sang, Haiqiang
[J]. ESC HEART FAILURE, 2023, 10 (04): : 2524 - 2533
[45] Baseline Characteristics of Patients With HF With Mildly Reduced and Preserved Ejection Fraction DELIVER Trial
Solomon, Scott D.
Vaduganathan, Muthiah
Claggett, Brian L.
de Boer, Rudolf A.
DeMets, David
Hernandez, Adrian F.
Inzucchi, Silvio E.
Kosiborod, Mikhail N.
Lam, Carolyn S. P.
Martinez, Felipe
Shah, Sanjiv J.
Belohlavek, Jan
Chiang, Chern-En
Borleffs, C. Jan Willem
Comin-Colet, Josep
Dobreanu, Dan
Drozdz, Jaroslaw
Fang, James C.
Alcocer Gamba, Marco Antonio
Al Habeeb, Waleed
Han, Yaling
Cabrera Honorio, Jose Walter
Janssens, Stefan P.
Katova, Tsvetana
Kitakaze, Masafumi
Merkely, Bela
O'Meara, Eileen
Kerr Saraiva, Jose Francisco
Tereschenko, Sergey N.
Thierer, Jorge
Vardeny, Orly
Verma, Subodh
Vinh, Pham Nguyen
Wilderang, Ulrica
Zaozerska, Natalia
Lindholm, Daniel
Petersson, Magnus
McMurray, John J. V.
[J]. JACC-HEART FAILURE, 2022, 10 (03) : 184 - 197
[46] Myeloperoxidase Inhibition in Heart Failure With Preserved or Mildly Reduced Ejection Fraction: SATELLITE Trial Results
Lam, Carolyn S. P.
Lund, Lars H.
Shah, Sanjiv J.
Voors, Adriaan A.
Erlinge, David
Saraste, Antti
Pirazzi, Carlo
Grove, Erik L.
Barasa, Anders
Schou, Morten
Aziz, Ahmed
Svedlund, Sara
van Wijngaarden, Jan
Lindstedt, Eva-Lotte
Gustavsson, Andreas
Nelander, Karin
Garkaviy, Pavlo
Gan, Li-Ming
Gabrielsen, Anders
[J]. JOURNAL OF CARDIAC FAILURE, 2024, 30 (01) : 104 - 110
[47] Effects of dapagliflozin in type 2 diabetes and heart failure with mildly reduced or preserved ejection fraction across the background of glucose-lowering therapy in DELIVER
Vaduganathan, M.
Inzucchi, S. E.
Claggett, B. L.
Kulac, I.
de Boer, R. A.
Desai, A. S.
Docherty, K. F.
Hernandez, A. F.
Kosiborod, M. N.
Jhund, P. S.
Lam, C. S. P.
Martinez, F. A.
Shah, S. J.
McMurray, J. J. V.
Solomon, S. D.
[J]. DIABETOLOGIA, 2023, 66 (SUPPL 1) : S91 - S92
[48] Association of Dapagliflozin vs Placebo With Individual Kansas City Cardiomyopathy Questionnaire Components in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction A Secondary Analysis of the DELIVER Trial
Peikert, Alexander
Chandra, Alvin
Kosiborod, Mikhail N.
Claggett, Brian L.
Desai, Akshay S.
Jhund, Pardeep S.
Lam, Carolyn S. P.
Inzucchi, Silvio E.
Martinez, Felipe A.
de Boer, Rudolf A.
Hernandez, Adrian F.
Shah, Sanjiv J.
Janssens, Stefan P.
Belohlavek, Jan
Borleffs, C. Jan Willem
Dobreanu, Dan
Langkilde, Anna Maria
Bengtsson, Olof
Petersson, Magnus
McMurray, John J. V.
Solomon, Scott D.
Vaduganathan, Muthiah
[J]. JAMA CARDIOLOGY, 2023, 8 (07) : 684 - 690
[49] Letter by Wang Regarding Article, "Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER Trial"
Wang, Junwen
[J]. CIRCULATION, 2024, 150 (06) : e106 - e106
[50] Effects of dapagliflozin in heart failure with preserved ejection fraction and chronic obstructive pulmonary disease: an analysis of the DELIVER trial
Butt, J.
Lu, H.
Kondo, T.
Bachus, E.
De Boer, R. A.
Hernandez, A.
Inzucchi, S.
Jhund, P. S.
Kosiborod, M.
Lam, C.
Martinez, F.
Shah, S. J.
Vaduganathan, M.
Solomon, S. D.
Mcmurray, J. J. V.
[J]. EUROPEAN HEART JOURNAL, 2023, 44

← 1 2 3 4 5 →